News

Marc Serota, MD, discussed upcoming systemic JAK inhibitors, the value of ruxolitinib cream and phototherapy, and a personalized multimodal approach to improve repigmentation outcomes.

The exclusive event brought together physician assistants and nurse practitioners from across the country to review complex atopic dermatitis, psoriasis, chronic hand eczema, and hidradenitis suppurativa patient cases.

Marc Serota, MD, notes that areas lacking hair follicles respond more slowly to therapy and benefit from long-term, low-risk use of topical ruxolitinib.

Explore the latest advancements and expert insights from the SDPA Fall 2025 Meeting held in San Antonio, Texas.

Nemolizumab shows significant efficacy in reducing pruritus and improving skin clearance in patients with prurigo nodularis, offering new therapeutic hope.

Karan Lal, DO, explores the transformative role of GLP-1 therapies in dermatology, highlighting their potential in treating inflammatory skin diseases and enhancing aesthetic care.

Experts discuss essential skin care strategies for sensitive skin, emphasizing evidence-based cleansing and moisturizing to restore the compromised skin barrier.

Marc Serota, MD, outlines how ruxolitinib cream supports gradual, sustained repigmentation, highlights the significance of “islands” of early pigment return, and discusses when to escalate or combine modalities to optimize outcomes.

Shannon Trotter, DO, and Renata Block, DMSc, MMS, PA-C, discuss social media's impact on dermatology, highlighting trends, misinformation, and the need for clinician engagement.

Lindsay Ackerman, MD, FAAD, shares practical insights on managing vitiligo with topical ruxolitinib, addressing patient expectations, safety, and evolving research gaps.

FDA updates labeling for menopausal hormone therapy, removing broad boxed warnings and adding guidance for younger symptomatic patients.

Joseph Gatti, DMSc, MPAS, MBA, PA-C, discusses the impact of social media and AI on dermatology, urging professionals to adapt and educate in a rapidly evolving landscape.

Experts discuss effective strategies for managing facial hyperpigmentation, emphasizing personalized treatment plans and the importance of sun protection.

Heather Goff, MD, MPH, discusses her role as SDPA Medical Director and the vital collaboration between dermatology PAs and physicians at the 2025 fall conference.

The first-in-class mast cell–selective c-Kit inhibitor ALY-301 enters clinical testing for cold urticaria in Germany.

Discover how the SDPA Diplomate Fellowship has evolved with innovative learning tools, enhancing education for dermatology PAs at the Fall 2025 conference.

The topline data support advancing INF904 into larger, controlled trials as a potential convenient alternative to injectable biologics.

Experts discuss icotrokinra's potential to revolutionize psoriasis treatment with oral therapies, emphasizing efficacy, safety, and patient-centered care at EADV 2025.

Catch up on coverage from the fourth day of the 2025 SDPA Fall Conference held in San Antonio, Texas.

Heather Goff, MD, MPH, shares vital insights on lifestyle, ethics, and cutaneous lymphomas at SDPA Fall 2025, highlighting the future of dermatology.

Renata Block, DMSc, MMS, PA-C, explores how AI could enhance dermatology, improving skin cancer diagnosis while emphasizing the vital role of human clinicians in patient care.

Joseph Gatti, DMSc, MPAS, MBA, highlights the importance of collaboration between PAs and dermatologists, emphasizing mutual respect and the role of PAs in enhancing patient care.

Andrew Baker, MBA, MPAS, PA-C, discusses leadership and inclusivity in dermatology at the SDPA Fall Conference, emphasizing collaboration and member engagement for future growth.

Catch up on coverage from the third day of the 2025 SDPA Fall Conference held in San Antonio, Texas.

Harrison Nguyen, MD, shares groundbreaking insights on CSU, vasculitis, and bullous diseases at the SDPA Fall 2025 conference, enhancing dermatologic education.

Shannon Trotter, DO, explores social media's impact on dermatology, lichenoid disorders, and granuloma annulare at SDPA Fall 2025.

Hussein Abbas, MD, PhD, discusses systemic mastocytosis challenges and the essential collaboration needed for optimal patient care.

Explore how a groundbreaking initiative by Hayden Middleton, PA-C, bridges dermatology and nutrition, enhancing patient care and clinician fulfillment.

Catch up on coverage from the second day of the 2025 SDPA Fall Conference held in San Antonio, Texas.

Kassandra Holzem, MD, shares vital insights on dermatology red flags and GVHD management, enhancing oncology care at SDPA Fall 2025.